Alkem Laboratories Ltd.

View in App
4910.40 +42.75 ▲0.9%

26 April 2024, 04:02:41 PM
Volume: 160,192

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alkemlabs.com
Market Cap 58,604.78 Cr.
Enterprise Value(EV) 56,545.32 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 131.58 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.25 Trailing Twelve Months Ending 2023-12
Industry PE 41.99 Trailing Twelve Months Ending 2023-12
Book Value / Share 873.73 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.61 Calculated using Price: 4,901.50
Dividend Yield 1.02 Period Ending 2023-03
No. of Shares Subscribed 11.96 Cr. 119,565,000 Shares
FaceValue 2
About Alkem Laboratories Ltd.
The company is one of India's foremost global pharmaceutical company. The company is engaged in the development, manufacture and marketing of pharmaceuticals with operational footprints across different countries. In India, it has a formidable presence in several therapy segments and consistently features amongst the top ten pharmaceutical companies. Steered by its industry experience of over four decades, it offers high-quality branded generics, generic drugs, active pharmaceutical ingredients and nutraceuticals.

Alkem Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alkem Laboratories Ltd. Performance

View details >>
1 Day
+0.88%
1 Week
+5.58%
1 Month
+2.52%
3 Month
-1.23%
6 Month
+36.96%
1 Year
+43.52%
2 Year
+48.31%
5 Year
+188.26%
10 Year

Alkem Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.03 22.48 22.18 13.69 15.02 19.82 23.91 20.99 11.39
Return on Capital Employed (%) 13.27 23.1 21.31 17.86 16.49 18.71 22.56 18.69 13.09
Return on Assets (%) 8.16 14.59 16.61 9.91 10.66 13.92 16.66 14.5 7.99

Alkem Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,999 3,692 4,468 4,864 5,439 6,161 7,377 8,638 9,045 9,842
Non Curr. Liab. 201 -306 -401 -359 -289 -541 -751 -893 -688 -643
Curr. Liab. 2,006 1,538 1,690 2,383 2,218 3,245 3,604 4,805 3,707 3,912
Minority Int. 86 95 115 122 133 148 181 209 390 382
Equity & Liab. 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454 13,494
Non Curr. Assets 2,953 2,250 2,955 2,997 3,284 3,507 3,483 4,325 3,724 3,832
Curr. Assets 2,338 2,769 2,915 4,013 4,204 5,488 6,923 8,434 8,606 9,662
Misc. Exp. not W/O
Total Assets 5,291 5,018 5,872 7,010 7,501 9,013 10,411 12,760 12,454 13,494

Alkem Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3,743 4,925 5,688 6,392 7,357 8,344 8,865 10,634 11,599 12,634
Other Income 181 240 112 115 88 104 233 163 216 291
Total Income 3,924 5,165 5,800 6,507 7,445 8,449 9,098 10,797 11,815 12,926
Total Expenditure -3,322 -4,072 -4,689 -5,383 -6,242 -6,871 -6,923 -8,581 -9,990 -10,438
PBIDT 603 1,093 1,111 1,124 1,202 1,578 2,176 2,216 1,826 2,488
Interest -81 -71 -45 -55 -55 -65 -59 -52 -107 -115
Depreciation -71 -93 -101 -143 -193 -253 -275 -304 -310 -294
Taxation -59 -176 -60 -288 -181 -110 -224 -164 -298 -293
Exceptional Items -15 -103 -212
PAT 392 752 905 638 774 1,149 1,618 1,680 1,007 1,575
Minority Interest -11 -13 -7 -13 -22 -33 -35 -23 -1
Share Associate
Other Related Items
Consolidated Net Profit 392 742 892 631 761 1,127 1,585 1,646 984 1,573
Adjusted EPS 33 62 75 53 64 94 133 138 82 132

Alkem Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 290 325 726 471 266 780 585 1,265 1,111 1,683
Cash Fr. Inv. 350 -237 202 -286 -357 -316 -741 -999 -1,435 113
Cash Fr. Finan. -600 -52 -927 -138 85 -379 79 -272 380 -1,761
Net Change 41 37 1 47 -7 84 -77 -5 55 35
Cash & Cash Eqvt 101 140 127 167 167 249 176 174 232 274

Alkem Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 57.13 57.14 57.16 57.16 57.16 57.16 56.74 56.74 56.74
Public 42.87 42.86 42.84 42.84 42.84 42.84 43.26 43.26 43.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Alkem Laboratories Ltd. Announcements

View details >>
Fri, 26 Apr 2024
Updates
Alkem Laboratories Limited has informed the Exchange regarding 'Application for Reclassification under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
Thu, 25 Apr 2024
Updates
Alkem Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR)- Regulatory Order'.
Tue, 16 Apr 2024
Updates
Alkem Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Alkem Laboratories Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Above Previous High for 2 Days Closing Above Previous High for 2 Days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 6 Months High Increase in 6 Months

Alkem Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Alkem Laboratories Ltd. FAQ's

What is Alkem Laboratories share price?
Can I buy Alkem Laboratories shares now?
What is the Dividend Yield of Alkem Laboratories?
What is the Market Cap of Alkem Laboratories?
What are the key metrics to analyse Alkem Laboratories?
What is the 52 Week High and Low of Alkem Laboratories?
What is the trend of Alkem Laboratories share price?